Outstanding Equity Awards at Fiscal Year-end 2016

The following table summarizes the outstanding equity awards of the named executives as of December 31, 2016.

    Option Awards(1)   Stock Awards(2)
Name   Option Grant Date   Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable(3)
  Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable(3)
  Option
Exercise
Price
($)
  Option
Expiration
Date
  Stock Award
Grant Date
  Number
of Shares
or Units
of Stock
That Have
Not Vested
(#)(4)
  Market
Value of
Shares or
Units of
Stock
That Have
Not Vested
($)(5)
  Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units, or
Other
Rights
that Have
Not Vested
(#)(6)
  Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units,
or Other
Rights that
Have Not
Vested
($)(5)
Mr. Wilson   02/26/2008   338,316   0   48.82   02/26/2018                    
  02/22/2010   417,576   0   31.41   02/22/2020                    
  02/22/2011   447,808   0   31.74   02/22/2021                    
  02/21/2012   444,060   0   31.56   02/21/2022                    
  02/12/2013   272,556   90,853   45.61   02/12/2023                    
  02/18/2014   206,158   103,079   52.18   02/18/2024   02/18/2014   64,265   4,763,322        
  02/18/2015   98,164   196,330   70.71   02/18/2025   02/18/2015           65,054   4,821,802
  02/11/2016   0   295,324   62.32   02/11/2026   02/11/2016           86,650   6,422,498
Mr. Shebik   02/22/2010   33,616   0   31.41   02/22/2020                    
  02/22/2011   35,197   0   31.74   02/22/2021                    
  02/21/2012   26,446   0   31.56   02/21/2022                    
  03/06/2012   35,014   0   31.00   03/06/2022                    
  02/12/2013   56,391   18,797   45.61   02/12/2023                    
  02/18/2014   48,192   24,097   52.18   02/18/2024   02/18/2014   15,023   1,113,505        
  02/18/2015   24,007   48,016   70.71   02/18/2025   02/18/2015           15,910   1,179,249
  02/11/2016   0   90,238   62.32   02/11/2026   02/11/2016           26,476   1,962,401
Mr. Civgin   02/12/2013   0   21,930   45.61   02/12/2023                    
  02/18/2014   56,224   28,113   52.18   02/18/2024   02/18/2014   17,527   1,299,101        
  02/18/2015   25,458   50,918   70.71   02/18/2025   02/18/2015           16,872   1,250,553
  02/11/2016   0   78,753   62.32   02/11/2026   02/11/2016           23,107   1,712,691
Ms. Fortin   10/05/2015   5,393   10,788   59.90   10/05/2025   10/05/2015   43,824   3,248,235   3,287   243,632
  02/11/2016   0   51,272   62.32   02/11/2026   02/11/2016           15,043   1,114,987
Mr. Winter   02/22/2011   101,869   0   31.74   02/22/2021                    
  02/21/2012   144,175   0   31.56   02/21/2022                    
  02/12/2013   79,495   26,499   45.61   02/12/2023                    
  02/18/2014   70,281   35,141   52.18   02/18/2024   02/18/2014   21,908   1,623,821        
  02/18/2015   33,077   66,155   70.71   02/18/2025   02/18/2015           21,921   1,624,785
  02/11/2016   0   105,004   62.32   02/11/2026   02/11/2016           30,809   2,283,563
(1)   The options granted in 2014 and after vest over three years: one-third will become exercisable on the anniversary of the grant date for each of the three years. The options granted in 2012 and 2013 vest over four years: 50% on the second anniversary date and 25% on each of the third and fourth anniversary dates. The other options vest in four installments of 25% on each of the first four anniversaries of the grant date. The exercise price of each option is equal to the closing price of Allstate’s common stock on the grant date. If there was no sale on the grant date, the closing price is calculated as of the last previous day on which there was a sale.
(2)   The awards listed in this table are PSAs, except for Ms. Fortin’s new hire award of restricted stock units in 2015. The 43,824 shares listed above represent three-fourths of her original award granted on October 5, 2015. The shares convert in four increments with one-fourth of the total shares converting on the anniversary of the grant date for the succeeding four years.
(3)   The aggregate value and aggregate number of exercisable and unexercisable in-the-money options as of December 31, 2016, for each of the named executives are as follows:
    Exercisable   Unexercisable
Name Aggregate
Number
(#)
Aggregate
Value
($)
Aggregate
Number
(#)
Aggregate
Value
($)
Mr. Wilson 2,224,638 76,899,780 685,586 9,006,081
Mr. Shebik 258,863 8,309,637 181,148 2,293,134
Mr. Civgin 81,682 1,320,366 179,714 2,344,939
Ms. Fortin 5,393 76,688 62,060 758,415
Mr. Winter 428,897 14,374,456 232,799 2,991,116
(4)   The PSAs vest in one installment on the day before the third anniversary of the grant date.
(5)   Amount is based on the closing price of our common stock of $74.12 on December 30, 2016.
(6)   The PSAs vest in one installment on the day before the third anniversary of the grant date. The number of shares that ultimately vest may range from 0 to 200% of the target depending on actual performance during the three-year performance period. For a description of the PSA program and the performance measures used, see pages 43-45 and 49. The number of PSAs reflected in this column for the 2015 and 2016 awards are the number of shares that would vest if the target level of performance is achieved. Final payouts under the PSAs will not be known until the respective performance period is completed.